Literature DB >> 24861046

Comparison of small-bowel mucosal injury between low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs: a capsule endoscopy study.

Ikue Watari1, Shiro Oka, Shinji Tanaka, Atsushi Igawa, Makoto Nakano, Taiki Aoyama, Shigeto Yoshida, Kazuaki Chayama.   

Abstract

BACKGROUND/AIMS: The differences in the severity of small-bowel toxicity induced by aspirin and non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) remain unclear. This study aimed at clarifying these differences in small-bowel mucosal injury by using capsule endoscopy (CE).
METHODS: We retrospectively compared the records of 78 and 40 obscure gastrointestinal bleeding patients receiving low-dose aspirin (LDA) and non-aspirin NSAIDs, respectively. All patients were found to have small-bowel mucosal injuries on CE. The two groups were compared for the number of small-bowel mucosal injuries and CE scores on the basis of the findings of CE.
RESULTS: The mean numbers of reddened lesions in the LDA group and non-aspirin NSAID group were 2.49 ± 3.15 and 1.65 ± 3.04; the mean numbers of erosions/ulcers 1.56 ± 3.75 and 6.08 ± 10.4, and the mean CE scores 154 ± 294 and 520 ± 758, respectively. The mean number of reddened lesions was significantly higher and the mean number of erosions/ulcers and CE scores significantly lower in the LDA group than in the other non-aspirin NSAID group.
CONCLUSION: Small-bowel mucosal injuries were significantly milder in the LDA group than in the non-aspirin NSAID group, though reddened lesions were more frequent in the LDA group.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24861046     DOI: 10.1159/000358287

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  8 in total

Review 1.  Small bowel injury in low-dose aspirin users.

Authors:  Hiroki Endo; Eiji Sakai; Takayuki Kato; Shotaro Umezawa; Takuma Higurashi; Hidenori Ohkubo; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2014-12-14       Impact factor: 7.527

2.  Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding.

Authors:  Panagiotis Tsibouris; Chissostomos Kalantzis; Periklis Apostolopoulos; Antonios Zalonis; Peter Edward Thomas Isaacs; Mark Hendrickse; Georgios Alexandrakis
Journal:  World J Gastrointest Endosc       Date:  2014-12-16

3.  Small-Bowel Lesions in Patients Taking Direct Oral Anticoagulants Detected Using Capsule Endoscopy.

Authors:  Minoru Yamaoka; Hiroyuki Imaeda; Naoki Hosoe; Kazuaki Yoneno; Ryu Kanno; Takashi Mitsufuji; Takahiro Sasaki; Yuji Akiyama; Hideki Ohgo; Yuichi Morohoshi; Takanori Kanai; Toshimasa Yamamoto; Toshihide Mimura; Haruhiko Ogata; Nobuo Araki; Keiji Yamamoto; Hidetomo Nakamoto
Journal:  Gastroenterol Res Pract       Date:  2020-08-11       Impact factor: 2.260

4.  Capsule endoscopy findings reflect the gastrointestinal conditions of patients with systemic sclerosis.

Authors:  Sumio Iio; Shiro Oka; Shinji Tanaka; Akihiko Sumioka; Akiyoshi Tsuboi; Takaki Nojima; Shintaro Hirata; Yoshimi Matsuo; Eiji Sugiyama; Michihiro Hide; Koji Arihiro; Kazuaki Chayama
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

5.  Characteristics and Treatment Outcomes of Small-bowel Angioectasia in Systemic Sclerosis Patients: A Retrospective Observational Study.

Authors:  Sumio Iio; Shiro Oka; Akihiko Sumioka; Akiyoshi Tsuboi; Hidenori Tanaka; Ken Yamashita; Yuichi Hiyama; Takahiro Kotachi; Hidehiko Takigawa; Ryohei Hayashi; Ryo Yuge; Yuji Urabe; Shinji Tanaka
Journal:  Intern Med       Date:  2021-08-24       Impact factor: 1.271

6.  Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study.

Authors:  Naoyoshi Nagata; Ryota Niikura; Atsuo Yamada; Toshiyuki Sakurai; Takuro Shimbo; Yuka Kobayashi; Makoto Okamoto; Yuzo Mitsuno; Keiji Ogura; Yoshihiro Hirata; Kazuma Fujimoto; Junichi Akiyama; Naomi Uemura; Kazuhiko Koike
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

7.  Effect of egualen sodium hydrate on small-intestinal mucosal damage induced by low-dose aspirin: a prospective randomized clinical trial.

Authors:  Munetaka Iguchi; Kazuki Kakimoto; Takanori Kuramoto; Kei Nakazawa; Minori Kubota; Yuki Hirata; Kaori Fujiwara; Satoshi Harada; Taisuke Sakanaka; Kazuhiro Ota; Shoko Edogawa; Yuichi Kojima; Sadaharu Nouda; Toshihiko Okada; Ken Kawakami; Toshihisa Takeuchi; Takuya Inoue; Kazuhide Higuchi
Journal:  J Clin Biochem Nutr       Date:  2018-01-11       Impact factor: 3.114

8.  The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin.

Authors:  Tsutomu Yoshihara; Yosuke Oikawa; Takayuki Kato; Takaomi Kessoku; Takashi Kobayashi; Shingo Kato; Noboru Misawa; Keiichi Ashikari; Akiko Fuyuki; Hidenori Ohkubo; Takuma Higurashi; Yoko Tateishi; Yoshiki Tanaka; Shunji Nakajima; Hiroshi Ohno; Koichiro Wada; Atsushi Nakajima
Journal:  Gut Microbes       Date:  2020-06-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.